| Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis A Kollár, RL Jones, S Stacchiotti, H Gelderblom, M Guida, G Grignani, ... Acta oncologica 56 (1), 88-92, 2017 | 170 | 2017 |
| Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways D Katz, A Lazar, D Lev Expert reviews in molecular medicine 11, e30, 2009 | 131 | 2009 |
| Prevention of severe menorrhagia in oncology patients with treatment‐induced thrombocytopenia by luteinizing hormone‐releasing hormone agonist and depo‐medroxyprogesterone acetate D Meirow, J Rabinovici, D Katz, R Or, D Ben‐Yehuda Cancer 107 (7), 1634-1641, 2006 | 108 | 2006 |
| Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: a propensity score matching analysis from … L D’Ambrosio, N Touati, JY Blay, G Grignani, R Flippot, AM Czarnecka, ... Cancer 126 (11), 2637-2647, 2020 | 104 | 2020 |
| More than 50 subtypes of soft tissue sarcoma: paving the path for histology-driven treatments D Katz, E Palmerini, SM Pollack American Society of Clinical Oncology Educational Book 38, 925-938, 2018 | 71 | 2018 |
| Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma D Katz, P Boonsirikamchai, H Choi, AJ Lazar, WL Wang, L Xiao, MS Park, ... Clinical Sarcoma Research 2, 1-7, 2012 | 66 | 2012 |
| Neoadjuvant imatinib for unresectable gastrointestinal stromal tumor D Katz, A Segal, Y Alberton, O Jurim, P Reissman, R Catane, NI Cherny Anti-cancer drugs 15 (6), 599-602, 2004 | 59 | 2004 |
| Beginning IVF treatments after age 30 increases the risk of breast cancer: results of a case–control study D Katz, O Paltiel, T Peretz, A Revel, N Sharon, B Maly, N Michan, ... The Breast Journal 14 (6), 517-522, 2008 | 45 | 2008 |
| Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study H Gelderblom, IR Judson, C Benson, O Merimsky, G Grignani, D Katz, ... Acta Oncologica 56 (12), 1769-1775, 2017 | 40 | 2017 |
| Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma RL Jones, D Katz, ET Loggers, D Davidson, ET Rodler, SM Pollack Medical Oncology 34, 1-5, 2017 | 38 | 2017 |
| Tumor STAT3 tyrosine phosphorylation status, as a predictor of benefit from adjuvant chemotherapy for breast cancer A Sonnenblick, B Uziely, H Nechushtan, L Kadouri, E Galun, JH Axelrod, ... Breast cancer research and treatment 138, 407-413, 2013 | 37 | 2013 |
| Patient and physician characteristics affect adherence to screening mammography: A population-based cohort study D Katz, AJ Tengekyon, NR Kahan, R Calderon-Margalit PloS one 13 (3), e0194409, 2018 | 34 | 2018 |
| Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy WL Wang, D Katz, DM Araujo, V Ravi, JA Ludwig, JC Trent, SR Patel, ... Clinical sarcoma research 2, 1-8, 2012 | 29 | 2012 |
| Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy SM Stemmer, M Steiner, S Rizel, N Ben-Baruch, B Uziely, DM Jakubowski, ... NPJ Breast Cancer 5 (1), 41, 2019 | 27 | 2019 |
| Anti-tumor effects of the Notch pathway in gastrointestinal stromal tumors AG Dumont, Y Yang, D Reynoso, D Katz, JC Trent, DP Hughes Carcinogenesis 33 (9), 1674-1683, 2012 | 26 | 2012 |
| Intratumoral immune-biomarkers and mismatch repair status in leiyomyosarcoma-potential predictive markers for adjuvant treatment: a pilot study JE Cohen, F Eleyan, A Zick, T Peretz, D Katz Oncotarget 9 (56), 30847, 2018 | 14 | 2018 |
| Pazolimus: pazopanib plus sirolimus following progression on pazopanib, a retrospective case series analysis D Katz, Y Azraq, F Eleyan, S Gill, T Peretz, O Merimsky BMC cancer 16, 1-8, 2016 | 14 | 2016 |
| A case of metastatic adamantinoma responding to treatment with pazopanib Y Cohen, JE Cohen, A Zick, M Orevi, V Doviner, R Rubinstein, ... Acta Oncologica 52 (6), 1229-1230, 2013 | 13 | 2013 |
| Lytic lesions in breast cancer D Katz, D Aharoni New England Journal of Medicine 351 (27), 2850-2850, 2004 | 12 | 2004 |
| Gemcitabine in combination with paclitaxel for advanced soft‑tissue sarcomas A Sonnenblick, F Eleyan, T Peretz, I Ospovat, O Merimsky, T Sella, ... Molecular and Clinical Oncology 3 (4), 829-832, 2015 | 9 | 2015 |
